Tradestie Institutional Equity Comparison Engine

ZSPC vs BHST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHST Overall Edge

BHST Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioHarvest Sciences Inc. Common Stock (BHST) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ZSPC trades at N/M Forward P/E with -116.2% operating margin (-43.2% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, ZSPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ZSPC N/M vs BHST N/M Fwd P/E
Growth & Margin Winner BHST
Op Margin -116.2% vs -18.0% ยท YoY -43.2% vs +3.8%
Momentum & Technical Winner BHST
1Y -97.6% vs -79.4% ยท 52W Pos 2% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZSPC NASDAQ
zSpace, Inc. Common stock
Services-Prepackaged Software
$0.24
-45.79% 1D
Market Cap $1.3M
1M Return +71.07%
1Y Return -97.58%
Forward P/E N/M
Unified AI Score
59.8 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 58.5
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZSPC -97.58% BHST -79.4% Spread: +30.61 pp (BHST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ZSPC Revenue BHST Revenue ZSPC Op. Margin BHST Op. Margin Margin Edge
FY2023 N/A $10M N/A -78.6% BHST
FY2024 $40M $30M -46.3% -27.7% BHST
FY2025 $30M $30M -79.5% -16.2% BHST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZSPC (2) vs BHST (6)
Institutional Metric ZSPC BHST Criterion Row Winner
Market Capitalization Scale $1.3M $29.9M Larger Scale BHST
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -43.2% +3.8% Higher Growth BHST
Operating Margin (TTM) Profitability -116.2% -18.0% Higher Margin BHST
Net Profit Margin Profitability -91.1% -31.2% Higher Margin BHST
Return on Equity (ROE) Capital Efficiency 0.0% -142.5% Higher ROE ZSPC
52-Week Range Position Momentum 2% ($0โ€“$10) 6% ($1โ€“$7) Stronger Trend BHST
Beta / 30D Volatility Risk Regime -10.63ฮฒ ยท 6994% Vol 0.25ฮฒ ยท 86% Vol Lower Realized Risk BHST
Unified Institutional Score Composite Signal 59.8 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite ZSPC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZSPC vs BHST Buy Guide
ZSPC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZSPC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZSPC nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.